CASSAVA SCIENCES INC. - COMMON STOCK
26.48
22-11月-24 16:44:58
15 分の遅延
株式
-5.70
-17.71%
本日の幅
26.02 - 31.40
ISIN
N/A
ソース
NASDAQ
-
26 7 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
21 7 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
21 6 2021 16:10:00 提供 Nasdaq GlobeNewswire
-
21 6 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the Raymond James 2021 Human Health Innovation Conference
17 6 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces the Appointment of Richard J. Barry to its Board of Directors
14 6 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer’s Disease
24 5 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces Initiation of Cognition Maintenance Study in Alzheimer’s disease
10 5 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Invited to Participate in B. Riley Securities’ Neuroscience Conference
27 4 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Invited by the NIH to Participate in Sachs 4th Annual Neuroscience Innovation Forum
26 4 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
21 4 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces Full-year 2020 Financial Results and Business Highlights
23 3 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
09 3 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the H.C. Wainwright Global Life Sciences Conference
08 3 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences to Present at SVB Leerink Global Healthcare Conference
23 2 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
22 2 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces Closing of $200 Million Registered Direct Offering
12 2 2021 17:08:17 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock
10 2 2021 06:15:06 提供 Nasdaq GlobeNewswire
-
08 2 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
02 2 2021 08:30:00 提供 Nasdaq GlobeNewswire